Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2011

01.10.2011 | Letter to the Editor

RAD51C germline mutations in Chinese women with familial breast cancer

verfasst von: Zhiyuan Pang, Lu Yao, Juan Zhang, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Yuntao Xie

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor, …
Literatur
1.
Zurück zum Zitat Li WF, Hu Z, Rao NY, Song CG, Zhang B, Cao MZ, Su FX, Wang YS, He PQ, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Liu XY, Zhou J, Wang L, Zhao L, Liu YB, Yuan WT, Yang L, Shen ZZ, Huang W, Shao ZM (2008) The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat 110(1):99–109PubMedCrossRef Li WF, Hu Z, Rao NY, Song CG, Zhang B, Cao MZ, Su FX, Wang YS, He PQ, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Liu XY, Zhou J, Wang L, Zhao L, Liu YB, Yuan WT, Yang L, Shen ZZ, Huang W, Shao ZM (2008) The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat 110(1):99–109PubMedCrossRef
2.
Zurück zum Zitat Wu GJ, Sinclair CS, Paape J, Ingle JN, Roche PC, James CD, Couch FJ (2000) 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes. Cancer Res 60(19):5371–5375PubMed Wu GJ, Sinclair CS, Paape J, Ingle JN, Roche PC, James CD, Couch FJ (2000) 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes. Cancer Res 60(19):5371–5375PubMed
3.
Zurück zum Zitat Dosanjh MK, Collins DW, Fan W, Lennon GG, Albala JS, Shen Z, Schild D (1998) Isolation and characterization of RAD51C, a new human member of the RAD51 family of related genes. Nucleic Acids Res 26(5):1179–1184PubMedCrossRef Dosanjh MK, Collins DW, Fan W, Lennon GG, Albala JS, Shen Z, Schild D (1998) Isolation and characterization of RAD51C, a new human member of the RAD51 family of related genes. Nucleic Acids Res 26(5):1179–1184PubMedCrossRef
4.
Zurück zum Zitat French CA, Masson JY, Griffin CS, O’Regan P, West SC, Thacker J (2002) Role of mammalian RAD51L2 (RAD51C) in recombination and genetic stability. J Biol Chem 277(22):19322–19330PubMedCrossRef French CA, Masson JY, Griffin CS, O’Regan P, West SC, Thacker J (2002) Role of mammalian RAD51L2 (RAD51C) in recombination and genetic stability. J Biol Chem 277(22):19322–19330PubMedCrossRef
5.
Zurück zum Zitat Liu Y, Masson JY, Shah R, O’Regan P, West SC (2004) RAD51C is required for Holliday junction processing in mammalian cells. Science 303(5655):243–246PubMedCrossRef Liu Y, Masson JY, Shah R, O’Regan P, West SC (2004) RAD51C is required for Holliday junction processing in mammalian cells. Science 303(5655):243–246PubMedCrossRef
6.
Zurück zum Zitat Sharan SK, Kuznetsov SG (2007) Resolving RAD51C function in late stages of homologous recombination. Cell Div 2:15PubMedCrossRef Sharan SK, Kuznetsov SG (2007) Resolving RAD51C function in late stages of homologous recombination. Cell Div 2:15PubMedCrossRef
7.
Zurück zum Zitat Smeenk G, de Groot AJ, Romeijn RJ, van Buul PP, Zdzienicka MZ, Mullenders LH, Pastink A, Godthelp BC (2010) Rad51C is essential for embryonic development and haploinsufficiency causes increased DNA damage sensitivity and genomic instability. Mutat Res 689(1–2):50–58PubMed Smeenk G, de Groot AJ, Romeijn RJ, van Buul PP, Zdzienicka MZ, Mullenders LH, Pastink A, Godthelp BC (2010) Rad51C is essential for embryonic development and haploinsufficiency causes increased DNA damage sensitivity and genomic instability. Mutat Res 689(1–2):50–58PubMed
8.
Zurück zum Zitat Badie S, Liao C, Thanasoula M, Barber P, Hill MA, Tarsounas M (2009) RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation. J Cell Biol 185(4):587–600PubMedCrossRef Badie S, Liao C, Thanasoula M, Barber P, Hill MA, Tarsounas M (2009) RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation. J Cell Biol 185(4):587–600PubMedCrossRef
9.
Zurück zum Zitat Vaz F, Hanenberg H, Schuster B, Barker K, Wiek C, Erven V, Neveling K, Endt D, Kesterton I, Autore F, Fraternali F, Freund M, Hartmann L, Grimwade D, Roberts RG, Schaal H, Mohammed S, Rahman N, Schindler D, Mathew CG (2010) Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet 42(5):406–409PubMedCrossRef Vaz F, Hanenberg H, Schuster B, Barker K, Wiek C, Erven V, Neveling K, Endt D, Kesterton I, Autore F, Fraternali F, Freund M, Hartmann L, Grimwade D, Roberts RG, Schaal H, Mohammed S, Rahman N, Schindler D, Mathew CG (2010) Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet 42(5):406–409PubMedCrossRef
10.
Zurück zum Zitat Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, Freund M, Lichtner P, Hartmann L, Schaal H, Ramser J, Honisch E, Kubisch C, Wichmann HE, Kast K, Deissler H, Engel C, Muller-Myhsok B, Neveling K, Kiechle M, Mathew CG, Schindler D, Schmutzler RK, Hanenberg H (2010) Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 42(5):410–414PubMedCrossRef Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, Freund M, Lichtner P, Hartmann L, Schaal H, Ramser J, Honisch E, Kubisch C, Wichmann HE, Kast K, Deissler H, Engel C, Muller-Myhsok B, Neveling K, Kiechle M, Mathew CG, Schindler D, Schmutzler RK, Hanenberg H (2010) Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 42(5):410–414PubMedCrossRef
Metadaten
Titel
RAD51C germline mutations in Chinese women with familial breast cancer
verfasst von
Zhiyuan Pang
Lu Yao
Juan Zhang
Tao Ouyang
Jinfeng Li
Tianfeng Wang
Zhaoqing Fan
Tie Fan
Benyao Lin
Yuntao Xie
Publikationsdatum
01.10.2011
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2011
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-011-1574-3

Weitere Artikel der Ausgabe 3/2011

Breast Cancer Research and Treatment 3/2011 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.